CD4 and neoplasm: The metastatic niche presentation of SFB epitopes activates tumor-infiltrating Th17 cells strongly, which then initiate a complex anti-tumor cytokine cascade through increased IL-17A and IFN-γ production by CD4+ T cells and CD8+ T cells, and natural killer cells.